Today: The Brokerages Set NuStar GP Holdings, LLC (NSH) PT at $27.17

The Brokerages Set NuStar GP Holdings, LLC (NSH) PT at $27.17

Shares of NuStar GP Holdings, LLC (NYSE:NSH) have earned an average rating of “Hold” from the eight analysts that are covering the firm. One investment analyst has rated the stock with a sell recommendation, five have issued a hold recommendation and two have issued a buy recommendation on the company. The average 12-month target price among analysts that have covered the stock in the last year is $27.17.

A number of research firms have issued reports on NSH. Mizuho began coverage on shares of NuStar GP Holdings in a research report on Thursday, September 29th. They issued a “neutral” rating and a $26.00 target price for the company. TheStreet downgraded shares of NuStar GP Holdings from a “hold” rating to a “sell” rating in a research report on Friday, September 2nd. US Capital Advisors reiterated a “hold” rating on shares of NuStar GP Holdings in a research report on Wednesday, September 21st. Zacks Investment Research upgraded shares of NuStar GP Holdings from a “hold” rating to a “buy” rating and set a $28.00 target price for the company in a research report on Wednesday, October 5th. Finally, Citigroup Inc. upgraded shares of NuStar GP Holdings from a “neutral” rating to a “buy” rating and increased their target price for the stock from $26.00 to $29.00 in a research report on Friday, August 12th.

In other NuStar GP Holdings news, Director William E. Greehey purchased 16,308 shares of the company’s stock in a transaction dated Friday, August 12th. The shares were bought at an average price of $24.72 per share, for a total transaction of $403,133.76. Following the purchase, the director now directly owns 8,584,823 shares in the company, valued at approximately $212,216,824.56. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director James F. Clingman sold 5,550 shares of the stock in a transaction on Wednesday, September 28th. The stock was sold at an average price of $25.35, for a total transaction of $140,692.50. Following the transaction, the director now owns 40,947 shares in the company, valued at approximately $1,038,006.45. The disclosure for this sale can be found here.

Several hedge funds and other institutional investors have recently made changes to their positions in the company. IFP Advisors Inc raised its position in shares of NuStar GP Holdings by 1.3% in the first quarter. IFP Advisors Inc now owns 4,856 shares of the company’s stock valued at $101,000 after buying an additional 60 shares during the period. Beach Investment Counsel Inc. PA acquired a new position in shares of NuStar GP Holdings during the second quarter valued at approximately $203,000. Cannell Peter B & Co. Inc. acquired a new position in shares of NuStar GP Holdings during the second quarter valued at approximately $210,000. M&T Bank Corp acquired a new position in shares of NuStar GP Holdings during the second quarter valued at approximately $213,000. Finally, Fiduciary Financial Services of The Southwest Inc. TX acquired a new position in shares of NuStar GP Holdings during the second quarter valued at approximately $229,000.

NuStar GP Holdings (NYSE:NSH) opened at 24.49 on Wednesday. The firm has a 50-day moving average of $24.72 and a 200-day moving average of $24.36. The firm has a market cap of $1.05 billion, a price-to-earnings ratio of 17.09 and a beta of 1.02. NuStar GP Holdings has a one year low of $12.86 and a one year high of $29.72.

NuStar GP Holdings (NYSE:NSH) last issued its quarterly earnings results on Tuesday, August 2nd. The company reported $0.35 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.36 by $0.01. Analysts anticipate that NuStar GP Holdings will post $1.48 EPS for the current year.

Related posts

Leave a Comment